Case study: MMTS Mini tabs child-friendly dosing
Posted: 20 May 2021 | ADARE Pharma Solutions | No comments yet
MMTS Mini tabs delivers child-friendly, broad-range dosing for toddlers.
A European-based pharmaceutical company wanted to improve their pancreatic enzyme product (PEP) delivery to patients who have difficulty swallowing several capsules a day. Adare Pharma Solutions scientists paired the API with Adare’s MMTS Mini tabs technology due to its ability to be opened and sprinkled onto soft foods. With the MMTS Mini tabs technology, patients of all ages needing this API now benefit from this highly flexible delivery system.
Related content from this organisation
- Maintaining EU MDR certification: a spotlight on post‑market clinical follow-up
- Formulation, Development & Delivery In-Depth Focus 2021
- Scientific briefing: Formulation-Monodisperse CR quetiapine microspheres
- Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
- Scientific briefing: Dissolution development Parvulet technology with oral tablets
Related topics
Analytical techniques, Biopharmaceuticals, Excipients, Formulation, Good Manufacturing Practice (GMP), Manufacturing, Research & Development (R&D)
